The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and you're describing C peptide which you mention is a it's sort of a fragment of insulin it's a blood test that we do to measure your body's endogenous production and you've seen c-peptide levels rise again and type 1 diabetics when they decide that's pretty remarkable
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and so in this case what's so interesting is this nineteen year old man with autoimmune illness and attack on his pancreas leading to decreased insulin production presumably because of destruction of the beta cells and then c-peptide is a is a fragment of insulin that we can measure in the blood that's more stable minute to minutes when we're actually want to see insulin levels in the blood or insulin surrogate levels we measure C peptide for him to have a restored three-fold elevation of c-peptide suggest that he had cessation of the autoimmune attack on his pancreas